Log In
|
Sign Up
Analytics Tools
Stock Screener
Strategy Backtester
Stock Quote
Stock Chart
Watch Lists
Portfolio Tracker
Trade Alert
Crypto Screener
Crypto Backtest
Correlation
Quick Screens
Moving Averages
Oscillators
Trend Indicators
Line Studies
Chart Patterns
Channels
Volatility
Relative Strength
Financial Strength
Ichimoku
Price Action
Volume
Fundamental Data
Financial Metrics
To Industry Ratios
Dividend
In the Spotlight
Market Breadth
Cryptocurrency
Fund Screens
Intrinsic Value
Earnings Growth
Solid Dividends
Dogs of the Dow
Growth Leaders
Help
Help Topics
FAQ
What's New
Education
Articles
Contact Us
Get
Clinuvel Pharmaceuticals Ltd
NASDAQ • Healthcare • Biotechnology • Quote as of 08/07/2026
Company Profile
Industry
Biotechnology
Sector
Healthcare
Exchange
NASDAQ
Market Capitalization
344.93 mln
Float
43.65 mln
EPS
0.45
Marginal
P / E
14.29
Fair value
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.46
Borderline
Debt / Equity
0.00
Debt-free
Pre-Tax Margin
45%
Very strong margin
Key Fundamentals
EPS
0.45
P/E
14.29
ROE
13.91
RPS
1.25
ROIC
99.78
ROA
12.65
Interest Cover
8.49
EBITDA, mln
32.99
EV / EBITDA
5.80
EV / EBIT
5.93
Revenue, mln
63.19
EV / Revenue
3.03
Financial Strength
Altman Z-Score
12.24
Piotroski F-Score
6
/ 9
Beneish M-Score
-2.46
Price to Lynch Fair Value
0.55
Price to Graham Number
1.22
Shiller PE Ratio
22.80
Price Performance & Relative Strength
Period
Price Performance
Relative Strength
1 Week
2.93%
58
/ 100
Disclaimer
-
Privacy Policy
-
Terms Of Service
-
Cookie Use Policy
-
FAQ
-
Contact Us
